Center for Childhood Cancer Research

Home News & Events CCCR Publications from July 1st 2010 to June 30th 2011

CCCR Publications from July 1st 2010 to June 30th 2011

Oncology CCCR Faculty

  1. Dubois SG, Shusterman S, Ingle AM, Ahern CH, Reid JM, Wu B, Baruchel S, Glade Bender J, Ivy P, Grier HE, Adamson PC, Blaney SM. Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study. Clin Cancer Res. 2011 Jun 20. [Epub ahead of print] PubMed PMID: 21690570.
  2. Norris RE, Minturn JE, Brodeur GM, Maris JM, Adamson PC. Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma. Cancer Chemother Pharmacol. 2011 Apr 12. [Epub ahead of print] PubMed PMID: 21484309.
  3. Barrett JS, Narayan M, Patel D, Zuppa AF, Adamson PC. Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance. BMC Pediatr. 2011 Apr 2;11:25. PubMed PMID: 21457572; PubMed Central PMCID: PMC3076266.
  4. Aplenc R, Blaney SM, Strauss LC, Balis FM, Shusterman S, Ingle AM, Agrawal S, Sun J, Wright JJ, Adamson PC. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. J Clin Oncol. 2011 Mar 1;29(7):839-44. Epub 2011 Jan 24. PubMed PMID: 21263099; PubMed Central PMCID: PMC3068059.
  5. Berg SL, Cairo MS, Russell H, Ayello J, Ingle AM, Lau H, Chen N, Adamson PC, Blaney SM. Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol. 2011 Jan 20;29(3):316-23. Epub 2010 Dec 13. PubMed PMID: 21149673; PubMed Central PMCID: PMC3056465.
  6. Su JM, Li XN, Thompson P, Ou CN, Ingle AM, Russell H, Lau CC, Adamson PC, Blaney SM. Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report. Clin Cancer Res. 2011 Feb 1;17(3):589-97. Epub 2010 Nov 29. PubMed PMID: 21115653; PubMed Central PMCID: PMC3064523.
  7. Fox E, Aplenc R, Bagatell R, Chuk MK, Dombi E, Goodspeed W, Goodwin A, Kromplewski M, Jayaprakash N, Marotti M, Brown KH, Wenrich B, Adamson PC, Widemann BC, Balis FM. A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors. J Clin Oncol. 2010 Dec 10;28(35):5174-81. Epub 2010 Nov 8. PubMed PMID: 21060028; PubMed Central PMCID: PMC3020690.
  8. Skolnik JM, Zhang AY, Barrett JS, Adamson PC. Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer. Ther Drug Monit. 2010 Dec;32(6):741-8. PubMed PMID: 20962707; PubMed Central PMCID: PMC2998595.
  9. Widemann BC, Arceci RJ, Jayaprakash N, Fox E, Zannikos P, Goodspeed W, Goodwin A, Wright JJ, Blaney SM, Adamson PC, Balis FM. Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 Feb;56(2):226-33. doi: 10.1002/pbc.22775. Epub 2010 Sep 21. PubMed PMID: 20860038.
  10. Souid AK, Dubowy RL, Ingle AM, Conlan MG, Sun J, Blaney SM, Adamson PC. A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study. Pediatr Blood Cancer. 2010 Dec 15;55(7):1323-8. doi: 10.1002/pbc.22609. Epub 2010 Aug 13. PubMed PMID: 20712019; PubMed Central PMCID: PMC3053384.
  11. Lipsitz E, Moorthy G, Mosse Y, Fox E, Adamson PC. A sensitive and selective liquid chromatography/tandem mass spectrometry method for determination of MLN8237 in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Sep 1;878(25):2369-73. Epub 2010 Jul 3. PubMed PMID: 20685183; PubMed Central PMCID: PMC2940716.
  12. Widemann BC, Balis FM, Kim A, Boron M, Jayaprakash N, Shalabi A, O'Brien M, Eby M, Cole DE, Murphy RF, Fox E, Ivy P, Adamson PC. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol. 2010 Sep 1;28(25):3979-86. Epub 2010 Aug 2. PubMed PMID: 20679598; PubMed Central PMCID: PMC2940396.
  13. Beaty O 3rd, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep;55(3):440-5. PubMed PMID: 20658614.
  14. Fouladi M, Park JR, Stewart CF, Gilbertson RJ, Schaiquevich P, Sun J, Reid JM, Ames MM, Speights R, Ingle AM, Zwiebel J, Blaney SM, Adamson PC. Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. J Clin Oncol. 2010 Aug 1;28(22):3623-9. Epub 2010 Jul 6. PubMed PMID: 20606092; PubMed Central PMCID: PMC2917318.
  15. George RE, Lahti JM, Adamson PC, Zhu K, Finkelstein D, Ingle AM, Reid JM, Krailo M, Neuberg D, Blaney SM, Diller L. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct;55(4):629-38. PubMed PMID: 20589651; PubMed Central PMCID: PMC3025700.
  16. Berg SL, Winick N, Ingle AM, Adamson PC, Blaney SM. Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study. Pediatr Blood Cancer. 2010 Jul 15;55(1):119-22. PubMed PMID: 20486176; PubMed Central PMCID: PMC2911979.
  17. Fox E, Maris JM, Cohn SL, Goodspeed W, Goodwin A, Kromplewski M, Medina D, Xiong H, Krivoshik A, Widemann B, Adamson PC, Balis FM. Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors. Cancer Chemother Pharmacol. 2010 Sep;66(4):737-43. Epub 2010 Jan 1. PubMed PMID: 20044751.
  18. Kazak AE, Barakat LP, Ditaranto S, Biros D, Hwang WT, Beele D, Kersun L, Alderfer MA, Mougianis I, Hocking MC, Reilly A. Screening for psychosocial risk at pediatric cancer diagnosis: the psychosocial assessment tool. J Pediatr Hematol Oncol. 2011 May;33(4):289-94. PubMed PMID: 21516024.
  19. Barakat LP, Alderfer MA. Introduction to special issue: advancing the science of family assessment in pediatric psychology. J Pediatr Psychol. 2011 Jun;36(5):489-93. Epub 2011 Jan 11. PubMed PMID: 21227913.
  20. Power TJ, Robins PM, Watkins MW, Rourke MT, Alderfer MA. Determining readiness for predoctoral internship training: the process of developing a screening measure. J Clin Psychol. 2011 Jan;67(1):6-16. doi: 10.1002/jclp.20738. Epub 2010 Oct 11. PubMed PMID: 20939022.
  21. Phipps S, Barrera M, Vannatta K, Xiong X, Doyle JJ, Alderfer MA. Complementary therapies for children undergoing stem cell transplantation: report of a multisite trial. Cancer. 2010 Aug 15;116(16):3924-33. PubMed PMID: 20626016; PubMed Central PMCID: PMC2919609.
  22. Marsac ML, Alderfer MA. Psychometric Properties of the FACES-IV in a Pediatric Oncology Population. J Pediatr Psychol. 2011 Jun;36(5):528-38. Epub 2010 Feb 10. PubMed PMID: 20147435; PubMed Central PMCID: PMC3131703.
  23. Alderfer MA, Long KA, Lown EA, Marsland AL, Ostrowski NL, Hock JM, Ewing LJ. Psychosocial adjustment of siblings of children with cancer: a systematic review. Psychooncology. 2010 Aug;19(8):789-805. Review. PubMed PMID: 19862680.
  24. Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatr Blood Cancer. 2011 May 25. doi: 10.1002/pbc.23192. [Epub ahead of print] PubMed PMID: 21618417.
  25. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, Fuchs BD, Lanken PN, Albelda SM, Rushefski M, Aplenc R, Abramova H, Atochina-Vasserman EN, Beers MF, Calfee CS, Cohen MJ, Pittet JF, Christiani DC, O'Keefe GE, Ware LB, May AK, Wurfel MM, Hakonarson H, Christie JD. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med. 2011 May 15;183(10):1344-53. Epub 2011 Jan 21. PubMed PMID: 21257790; PubMed Central PMCID: PMC3114062.
  26. Johnson KA, Aplenc R, Bagatell R. Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatr Blood Cancer. 2011 Mar;56(3):425-31. PubMed PMID: 21072824.
  27. Aplenc R. Steps forward in neuroblastoma genetic epidemiology. Pediatr Blood Cancer. 2010 Aug;55(2):222-3. PubMed PMID: 20582945.
  28. Fisher BT, Zaoutis TE, Leckerman KH, Localio R, Aplenc R. Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study. Pediatr Blood Cancer. 2010 Oct;55(4):655-61. PubMed PMID: 20533519.
  29. Deyell RJ, Attiyeh EF. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Cancer Genet. 2011 Mar;204(3):113-21. Review. PubMed PMID: 21504710.
  30. Nguyen le B, Diskin SJ, Capasso M, Wang K, Diamond MA, Glessner J, Kim C, Attiyeh EF, Mosse YP, Cole K, Iolascon A, Devoto M, Hakonarson H, Li HK, Maris JM. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. PLoS Genet. 2011 Mar;7(3):e1002026. Epub 2011 Mar 17. PubMed PMID: 21436895; PubMed Central PMCID: PMC3060064.
  31. Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, Diskin SJ, Attiyeh EF, Sennett R, Norris G, Laudenslager M, Wood AC, Mayes PA, Jagannathan J, Winter C, Mosse YP, Maris JM. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3336-41. Epub 2011 Feb 2. PubMed PMID: 21289283; PubMed Central PMCID: PMC3044382.
  32. Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, Schnepp RW, Diamond M, Bosse K, Mayes PA, Glessner J, Kim C, Frackelton E, Garris M, Wang Q, Glaberson W, Chiavacci R, Nguyen L, Jagannathan J, Saeki N, Sasaki H, Grant SF, Iolascon A, Mosse YP, Cole KA, Li H, Devoto M, McGrady PW, London WB, Capasso M, Rahman N, Hakonarson H, Maris JM. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011 Jan 13;469(7329):216-20. Epub 2010 Dec 1. PubMed PMID: 21124317.
  33. Clericuzio C, Harutyunyan K, Jin W, Erickson RP, Irvine AD, McLean WH, Wen Y, Bagatell R, Griffin TA, Shwayder TA, Plon SE, Wang LL. Identification of a novel C16orf57 mutation in Athabaskan patients with Poikiloderma with Neutropenia. Am J Med Genet A. 2011 Feb;155A(2):337-42. doi: 10.1002/ajmg.a.33807. Epub 2010 Dec 22. PubMed PMID: 21271650; PubMed Central PMCID: PMC3069503.
  34. Bagatell R, Herzog CE, Trippett TM, Grippo JF, Cirrincione-Dall G, Fox E, Macy M, Bish J, Whitcomb P, Aikin A, Wright G, Yurasov S, Balis FM, Gore L. Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors. Clin Cancer Res. 2011 Feb 1;17(3):611-9. Epub 2010 Dec 2. PubMed PMID: 21127194.
  35. Bagatell R, London WB, Wagner LM, Voss SD, Stewart CF, Maris JM, Kretschmar C, Cohn SL. Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2011 Jan 10;29(2):208-13. Epub 2010 Nov 29. PubMed PMID: 21115869; PubMed Central PMCID: PMC3058276.
  36. Marcus L, Murphy R, Fox E, McCully C, Cruz R, Warren KE, Meyer T, McNiff E, Balis FM, Widemann BC. The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates. Cancer Chemother Pharmacol. 2011 Jun 26. [Epub ahead of print] PubMed PMID: 21706317.
  37. Fox E, Balis FM. Commentary. Clin Chem. 2010 Dec;56(12):1795. PubMed PMID: 21119037.
  38. Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE. A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res. 2011 Feb 1;17(3):569-80. Epub 2010 Nov 16. PubMed PMID: 21081657; PubMed Central PMCID: PMC3071989.
  39. Kim A, McCully C, Cruz R, Cole DE, Fox E, Balis FM, Widemann BC. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. Invest New Drugs. 2010 Nov 12. [Epub ahead of print] PubMed PMID: 21072558.
  40. Sepe DM, Ginsberg JP, Balis FM. Dexrazoxane as a cardioprotectant in children receiving anthracyclines. Oncologist. 2010;15(11):1220-6. Epub 2010 Nov 4. PubMed PMID: 21051660.
  41. Chuk MK, Cole DE, McCully C, Loktionova NA, Pegg AE, Parker RJ, Pauly G, Widemann BC, Balis FM, Fox E. Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model. Cancer Chemother Pharmacol. 2011 Jun;67(6):1291-7. Epub 2010 Aug 20. PubMed PMID: 20725726.
  42. Ziadni MS, Patterson CA, Pulgarón ER, Robinson MR, Barakat LP. Health-Related Quality of Life and Adaptive Behaviors of Adolescents with Sickle Cell Disease: Stress Processing Moderators. J Clin Psychol Med Settings. 2011 Jun 18. [Epub ahead of print] PubMed PMID: 21681659.
  43. Kazak AE, Barakat LP, Hwang WT, Ditaranto S, Biros D, Beele D, Kersun L, Hocking MC, Reilly A. Association of psychosocial risk screening in pediatric cancer with psychosocial services provided. Psychooncology. 2011 Jul;20(7):715-23. doi: 10.1002/pon.1972. Epub 2011 Apr 7. PubMed PMID: 21480432.
  44. Patterson CA, Barakat LP, Henderson PK, Nall F, Westin A, Dampier CD, Hsu LL. Comparing abstract numerical and visual depictions of risk in survey of parental assessment of risk in sickle cell hydroxyurea treatment. J Pediatr Hematol Oncol. 2011 Jan;33(1):4-9. PubMed PMID: 21178705.
  45. Pulgaron ER, Salamon KS, Patterson CA, Barakat LP. A problem-solving intervention for children with persistent asthma: a pilot of a randomized trial at a pediatric summer camp. J Asthma. 2010 Nov;47(9):1031-9. PubMed PMID: 20858029.
  46. Barakat LP, Schwartz LA, Salamon KS, Radcliffe J. A family-based randomized controlled trial of pain intervention for adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2010 Oct;32(7):540-7. PubMed PMID: 20686425; PubMed Central PMCID: PMC2950888.
  47. Daniel LC, Grant M, Kothare SV, Dampier C, Barakat LP. Sleep patterns in pediatric sickle cell disease. Pediatr Blood Cancer. 2010 Sep;55(3):501-7. PubMed PMID: 20658622.
  48. Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, Maguire MG, Balcer LJ. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011 Mar;151(3):542-9.e2. Epub 2011 Jan 12. PubMed PMID: 21232732; PubMed Central PMCID: PMC3053008.
  49. Minturn JE, Janss AJ, Fisher PG, Allen JC, Patti R, Phillips PC, Belasco JB. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors. Pediatr Blood Cancer. 2011 Jan;56(1):39-44. PubMed PMID: 21108437.
  50. Bluebond-Langner M, Belasco JB, DeMesquita Wander M. "I want to live, until I don't want to live anymore": involving children with life-threatening and life-shortening illnesses in decision making about care and treatment. Nurs Clin North Am. 2010 Sep;45(3):329-43. PubMed PMID: 20804881.
  51. Ho R, Minturn JE, Simpson AM, Iyer R, Light JE, Evans AE, Brodeur GM. The effect of P75 on Trk receptors in neuroblastomas. Cancer Lett. 2011 Jun 1;305(1):76-85. Epub 2011 Mar 17. PubMed PMID: 21419569; PubMed Central PMCID: PMC3070806.
  52. Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother Pharmacol. 2011 Feb 22. [Epub ahead of print] PubMed PMID: 21340605.
  53. Bunin GR, Felice MA, Davidson W, Friedman DL, Shields CL, Maidment A, O'Shea M, Nichols KE, Leahey A, Dunkel IJ, Jubran R, Rodriguez-Galindo C, Schmidt ML, Weinstein JL, Goldman S, Abramson DH, Wilson MW, Gallie BL, Chan HS, Shapiro M, Cnaan A, Ganguly A, Meadows AT. Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation. Int J Cancer. 2011 May 15;128(10):2393-404. doi: 10.1002/ijc.25565. PubMed PMID: 20648557; PubMed Central PMCID: PMC3124307.
  54. Khan S, Evans AA, Rorke-Adams L, Orjuela MA, Shiminski-Maher T, Bunin GR. Head injury, diagnostic X-rays, and risk of medulloblastoma and primitive neuroectodermal tumor: a Children's Oncology Group study. Cancer Causes Control. 2010 Jul;21(7):1017-23. Epub 2010 Mar 9. PubMed PMID: 20217209; PubMed Central PMCID: PMC3023159.
  55. Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: A pediatric blood and marrow transplant consortium study. Pediatr Blood Cancer. 2011 Sep;57(3):506-13. doi: 10.1002/pbc.22899. Epub 2010 Dec 1. PubMed PMID: 21744474.
  56. Baker KS, Bhatia S, Bunin N, Nieder M, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Pulsipher MA. NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: State of the Science, Future Directions. Biol Blood Marrow Transplant. 2011 Jun 29. [Epub ahead of print] PubMed PMID: 21723224.
  57. Nemecek ER, Ellis K, He W, Bunin NJ, Bajwa RS, Cheerva A, Cairo MS, Dvorak C, Duval M, Davies S, Eapen M, Gross TG, Hussein AA, Macmillan ML, Mehta PA, Pulsipher MA, Seber A, Woolfrey AE, Frangoul HA, Carpenter PA. Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission. Biol Blood Marrow Transplant. 2011 May 27. [Epub ahead of print] PubMed PMID: 21683798.
  58. Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: A pediatric blood and marrow transplant consortium study. Pediatr Blood Cancer. 2010 Dec 1. [Epub ahead of print] PubMed PMID: 21125619.
  59. Cable C, Finkel RS, Lehky TJ, Biassou NM, Wiggs EA, Bunin N, Pierson TM. Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings. Mol Genet Metab. 2011 Feb;102(2):207-9. Epub 2010 Oct 28. PubMed PMID: 21035368; PubMed Central PMCID: PMC3053057.
  60. Bunin N, Guzikowski V, Rand ER, Goldfarb S, Baluarte J, Meyers K, Olthoff KM. Solid organ transplants following hematopoietic stem cell transplant in children. Pediatr Transplant. 2010 Dec;14(8):1030-5. doi: 10.1111/j.1399-3046.2010.01401.x. Epub 2010 Sep 15. PubMed PMID: 20846242.
  61. Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, Klein C, Schlegel PG, Heinzmann A, Schneider M, Star√Ω J, van den Heuvel-Eibrink MM, Hasle H, Locatelli F, Sakai D, Archambeault S, Chen L, Russell RC, Sybingco SS, Ohh M, Braun BS, Flotho C, Loh ML. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet. 2010 Sep;42(9):794-800. Epub 2010 Aug 8. PubMed PMID: 20694012.
  62. Robinson BW, Germano G, Song Y, Abrams J, Scott M, Guariento I, Tiso N, Argenton F, Basso G, Rhodes J, Kanki JP, Look AT, Balice-Gordon RJ, Felix CA. mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues. Br J Haematol. 2011 Feb;152(3):307-21. doi: 10.1111/j.1365-2141.2010.08398.x. Epub 2010 Dec 14. PubMed PMID: 21155757.
  63. Felix CA. Infant leukemia 2010: a call to action for the west and the "four Asian Tigers". Pediatr Blood Cancer. 2010 Dec 15;55(7):1247-9. PubMed PMID: 20981686.
  64. Fisher MJ, Broome ME. Parent-provider communication during hospitalization. J Pediatr Nurs. 2011 Feb;26(1):58-69. Epub 2010 Jan 22. PubMed PMID: 21256413.
  65. Palmer SL, Hassall T, Evankovich K, Mabbott DJ, Bonner M, Deluca C, Cohn R, Fisher MJ, Morris EB, Broniscer A, Gajjar A. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol. 2010 Dec;12(12):1311-7. Epub 2010 Aug 16. PubMed PMID: 20713408; PubMed Central PMCID: PMC3018935.
  66. Youngstedt SD, Kline CE, Ginsberg JP, Zielinski MR, Hardin JW. Bright light treatment for high-anxious young adults: a randomized controlled pilot study. Depress Anxiety. 2011 Apr;28(4):324-32. doi: 10.1002/da.20784. Epub 2011 Jan 19. PubMed PMID: 21254315.
  67. Ginsberg JP. New advances in fertility preservation for pediatric cancer patients. Curr Opin Pediatr. 2011 Feb;23(1):9-13. Review. PubMed PMID: 21157350; PubMed Central PMCID: PMC3095100.
  68. Ginsberg JP. Educational paper: the effect of cancer therapy on fertility, the assessment of fertility and fertility preservation options for pediatric patients. Eur J Pediatr. 2011 Jun;170(6):703-8. Epub 2010 Dec 4. PubMed PMID: 21127904.
  69. Hobbie WL, Moab SM, Carlson CA, Gruccio D, Ginsberg JP. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma. Pediatr Blood Cancer. 2011 Mar;56(3):474-6. PubMed PMID: 21072832.
  70. Ginsberg JP, Goodman P, Leisenring W, Ness KK, Meyers PA, Wolden SL, Smith SM, Stovall M, Hammond S, Robison LL, Oeffinger KC. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010 Aug 18;102(16):1272-83. Epub 2010 Jul 23. PubMed PMID: 20656964; PubMed Central PMCID: PMC2948841.
  71. Ginsberg JP, Berry ME, Powell DA. Cardiac coherence and posttraumatic stress disorder in combat veterans. Altern Ther Health Med. 2010 Jul-Aug;16(4):52-60. Erratum in: Altern Ther Health Med. 2010 Sep-Oct;16(5):11. PubMed PMID: 20653296.
  72. Hobbie WL, Ogle SK, Reilly M, Ginsberg JP, Rourke M, Ratcliffe S, Deatrick JA. Identifying the educational needs of parents at the completion of their child's cancer therapy. J Pediatr Oncol Nurs. 2010 Jul-Aug;27(4):190-5. PubMed PMID: 20562388.
  73. Spunt SL, Grupp SA, Vik TA, Santana VM, Greenblatt DJ, Clancy J, Berkenblit A, Krygowski M, Ananthakrishnan R, Boni JP, Gilbertson RJ. Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumors. J Clin Oncol. 2011 Jul 20;29(21):2933-40. Epub 2011 Jun 20. PubMed PMID: 21690471.
  74. Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan KW, Ryan RE, Kellick M, Neudorf SM, Godder K, Sandler ES, Sahdev I, Grupp SA, Sanders JE, Wall DA. Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children's Oncology Group Study. Biol Blood Marrow Transplant. 2011 May 30. [Epub ahead of print] PubMed PMID: 21689773.
  75. Rozmus J, Schultz KR, Wynne K, Kariminia A, Satyanarayana P, Krailo M, Grupp SA, Gilman AL, Goldman FD. Early and Late Extensive Chronic Graft-versus-Host Disease in Children Is Characterized by Different Th1/Th2 Cytokine Profiles: Findings of the Children's Oncology Group Study ASCT0031. Biol Blood Marrow Transplant. 2011 May 25. [Epub ahead of print] PubMed PMID: 21669298.
  76. Sheen C, Vincent T, Barrett D, Horwitz EM, Hulitt J, Strong E, Grupp SA, Teachey DT. Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis. Br J Haematol. 2011 May 9. doi: 10.1111/j.1365-2141.2011.08696.x. [Epub ahead of print] PubMed PMID: 21554258.
  77. Kinjyo I, Gordon SM, Intlekofer AM, Dowdell K, Mooney EC, Caricchio R, Grupp SA, Teachey DT, Rao VK, Lindsten T, Reiner SL. Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin. J Immunol. 2010 Dec 15;185(12):7151-5. Epub 2010 Nov 12. PubMed PMID: 21076068; PubMed Central PMCID: PMC2997140.
  78. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM; Children's Oncology Group. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30;363(14):1324-34. PubMed PMID: 20879881; PubMed Central PMCID: PMC3086629.
  79. Grupp SA, June CH. Adoptive cellular therapy. Curr Top Microbiol Immunol. 2011;344:149-72. Review. PubMed PMID: 20700700.
  80. Cuvelier GD, Kariminia A, Fujii H, Aslanian S, Wall D, Goldman F, Grupp SA, Dunn SE, Krailo M, Shapiro LH, Gilman A, Schultz KR. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031. Bone Marrow Transplant. 2010 Nov;45(11):1653-7. Epub 2010 Mar 1. PubMed PMID: 20190833; PubMed Central PMCID: PMC3058262.
  81. Shields CL, Hogarty MD, Kligman BE, Christian C, Ehya H, Shields JA. Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy. J AAPOS. 2010 Dec;14(6):534-7. PubMed PMID: 21168078.
  82. Otsuru S, Rasini V, Bussolari R, Hofmann TJ, Dominici M, Horwitz EM. Cytokine-induced osteopoietic differentiation of transplanted marrow cells. Blood. 2011 Jun 29. [Epub ahead of print] PubMed PMID: 21715305.
  83. Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer. 2011 Jul 1;117(13):2883-91. doi: 10.1002/cncr.25900. Epub 2011 Jan 10. PubMed PMID: 21692049.
  84. Horwitz EM, Maziarz RT, Kebriaei P. MSCs in hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S21-9. Review. PubMed PMID: 21195306.
  85. Boorjian SA, Karnes RJ, Viterbo R, Rangel LJ, Bergstralh EJ, Horwitz EM, Blute ML, Buyyounouski MK. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer. 2011 Jan 10. [Epub ahead of print] PubMed PMID: 21225881; PubMed Central PMCID: PMC3139725.
  86. Horwitz EM, Horowitz MM, DiFronzo NL, Kohn DB, Heslop HE; Blood and Marrow Transplant Clinical Trials Network, State of the Science Cell and Gene Therapy Committee. Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2011 Feb;17(2):192-6. Epub 2010 Dec 21. PubMed PMID: 21182973.
  87. Horwitz EM. Building bone from blood vessels. Nat Med. 2010 Dec;16(12):1373-4. PubMed PMID: 21135844.
  88. Rosenthal SA, Bittner NH, Beyer DC, Demanes DJ, Goldsmith BJ, Horwitz EM, Ibbott GS, Lee WR, Nag S, Suh WW, Potters L; American Society for Radiation Oncology; American College of Radiology. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):335-41. Epub 2010 Nov 23. PubMed PMID: 21106306.
  89. Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol. 2010 Dec;33(6):599-603. PubMed PMID: 21063195.
  90. Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):437-44. Epub 2010 Nov 2. PubMed PMID: 21050673.
  91. Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, Horwitz EM, Veys P, Bonfim C, Al-Seraihy A. Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab. 2011 Feb;102(2):111-5. Epub 2010 Oct 25. PubMed PMID: 20980181.
  92. Canter D, Greenberg RE, Horwitz EM, Kutikov A, Li J, Long C, Buyyounouski M, Boorjian SA. Implantation of electromagnetic transponders following radical prostatectomy for delivery of IMRT. Can J Urol. 2010 Oct;17(5):5365-9. PubMed PMID: 20974028.
  93. Dominici M, Horwitz EM. Getting beneath the skin to understand MSC complexity. Cytotherapy. 2010 Jul;12(4):438-9. PubMed PMID: 20608761.
  94. Otsuru S, Hofmann TJ, Rasini V, Veronesi E, Dominici M, Horwitz EM. Osteopoietic engraftment after bone marrow transplantation: effect of inbred strain of mice. Exp Hematol. 2010 Sep;38(9):836-44. Epub 2010 May 4. PubMed PMID: 20447443.
  95. Chen X, Hofmann TJ, Otsuru S, Jethva R, Lind C, Monos D, Horwitz EM. A strategy for single nucleotide polymorphism analysis of chimerism for somatic cell therapy. Cytotherapy. 2010 Dec;12(8):1035-43. Epub 2010 Apr 29. PubMed PMID: 20429790.
  96. Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol. 2010 Jul;96(1):6-12. Epub 2010 Apr 17. PubMed PMID: 20400191.
  97. Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):65-70. Epub 2010 Apr 10. PubMed PMID: 20385457.
  98. Pulsipher MA, Horwitz EM, Haight AE, Kadota R, Chen AR, Frangoul H, Cooper LJ, Jacobsohn DA, Goyal RK, Mitchell D, Nieder ML, Yanik G, Cowan MJ, Soni S, Gardner S, Shenoy S, Taylor D, Cairo M, Schultz KR. Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant. 2010 Sep;16(9):1212-21. Epub 2010 Jan 14. Review. PubMed PMID: 20079865; PubMed Central PMCID: PMC2891395.
  99. Stuber ML, Meeske KA, Leisenring W, Stratton K, Zeltzer LK, Dawson K, Kazak AE, Zebrack B, Mertens AC, Robison LL, Krull KR. Defining medical posttraumatic stress among young adult survivors in the Childhood Cancer Survivor Study. Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):347-53. Epub 2011 May 25. PubMed PMID: 21762831; PubMed Central PMCID: PMC3140002.
  100. Kazak AE. Health psychology 2011-2016: welcome and opening comments. Health Psychol. 2011 May;30(3):247-50. PubMed PMID: 21553967.
  101. Doshi K, Kazak AE, Derosa BW, Schwartz LA, Hobbie W, Ginsberg J, Ittenbach RF. Measuring health-related beliefs of mothers of adolescent and young adult childhood cancer survivors. Fam Syst Health. 2011 Mar;29(1):55-63. PubMed PMID: 21417524.
  102. Marino BS, Drotar D, Cassedy A, Davis R, Tomlinson RS, Mellion K, Mussatto K, Mahony L, Newburger JW, Tong E, Cohen MI, Helfaer MA, Kazak AE, Wray J, Wernovsky G, Shea JA, Ittenbach R. External validity of the pediatric cardiac quality of life inventory. Qual Life Res. 2011 Mar;20(2):205-14. Epub 2010 Dec 25. PubMed PMID: 21188538.
  103. DeRosa BW, Kazak AE, Doshi K, Schwartz LA, Ginsberg J, Mao JJ, Straton J, Hobbie W, Rourke MT, Carlson C, Ittenbach RF. Development and validation of the health competence beliefs inventory in young adults with and without a history of childhood cancer. Ann Behav Med. 2011 Feb;41(1):48-58. PubMed PMID: 20936390.
  104. Feudtner C, Carroll KW, Hexem KR, Silberman J, Kang TI, Kazak AE. Parental hopeful patterns of thinking, emotions, and pediatric palliative care decision making: a prospective cohort study. Arch Pediatr Adolesc Med. 2010 Sep;164(9):831-9. PubMed PMID: 20819965.
  105. Marino BS, Tomlinson RS, Wernovsky G, Drotar D, Newburger JW, Mahony L, Mussatto K, Tong E, Cohen M, Andersen C, Shera D, Khoury PR, Wray J, Gaynor JW, Helfaer MA, Kazak AE, Shea JA; Pediatric Cardiac Quality of Life Inventory Testing Study Consortium. Validation of the pediatric cardiac quality of life inventory. Pediatrics. 2010 Sep;126(3):498-508. Epub 2010 Aug 30. PubMed PMID: 20805147.
  106. Lange BJ, Yang RK, Gan J, Hank JA, Sievers EL, Alonzo TA, Gerbing RB, Sondel PM. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 Therapy for Pediatric Acute Myeloid Leukemia. Pediatr Blood Cancer. 2011 Sep;57(3):398-405. doi: 10.1002/pbc.22966. Epub 2011 Jun 16. PubMed PMID: 21681921.
  107. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2011 May 25. doi: 10.1002/pbc.23201. [Epub ahead of print] PubMed PMID: 21618422.
  108. Buyse M, Squifflet P, Lange BJ, Alonzo TA, Larson RA, Kolitz JE, George SL, Bloomfield CD, Castaigne S, Chevret S, Blaise D, Maraninchi D, Lucchesi KJ, Burzykowski T. Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia. Blood. 2011 Jun 30;117(26):7007-13. Epub 2011 Apr 25. PubMed PMID: 21518931.
  109. Lange BJ, Woods WG. Ya gotta have heart. Pediatr Blood Cancer. 2011 Apr;56(4):513-4. doi: 10.1002/pbc.22997. Epub 2011 Jan 19. PubMed PMID: 21298732.
  110. Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Sep;55(3):414-20. PubMed PMID: 20658610; PubMed Central PMCID: PMC2990693.
  111. Houghton PJ, Lock R, Carol H, Morton CL, Phelps D, Gorlick R, Kolb EA, Keir ST, Reynolds CP, Kang MH, Maris JM, Wozniak AW, Gu Y, Wilson WR, Smith MA. Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Sep;57(3):443-53. doi: 10.1002/pbc.22921. Epub 2010 Dec 27. PubMed PMID: 21744473.
  112. Houghton PJ, Kang MH, Reynolds CP, Morton CL, Kolb EA, Gorlick R, Keir ST, Carol H, Lock R, Maris JM, Billups CA, Smith MA. Initial testing (Stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Jun 16. doi: 10.1002/pbc.23167. [Epub ahead of print] PubMed PMID: 21681929.
  113. Kolb EA, Gorlick R, Maris JM, Keir ST, Morton CL, Wu J, Wozniak AW, Smith MA, Houghton PJ. Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 May 31. doi: 10.1002/pbc.23157. [Epub ahead of print] PubMed PMID: 21630428.
  114. Lock RB, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Maris JM, Wozniak AW, Gorlick R, Kolb EA, Houghton PJ, Smith MA. Initial testing of the CENP-E inhibitor GSK923295A by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 May 16. doi: 10.1002/pbc.23176. [Epub ahead of print] PubMed PMID: 21584937.
  115. Houghton PJ, Lock R, Carol H, Morton CL, Gorlick R, Anders Kolb E, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups CA, Zhang MX, Madden SL, Teicher BA, Smith MA. Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 May 5. doi: 10.1002/pbc.23016. [Epub ahead of print] PubMed PMID: 21548007.
  116. Morton CL, Maris JM, Keir ST, Gorlick R, Kolb EA, Billups CA, Wu J, Smith MA, Houghton PJ. Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Apr 29. doi: 10.1002/pbc.23159. [Epub ahead of print] PubMed PMID: 21538824.
  117. Kang MH, Reynolds CP, Houghton PJ, Alexander D, Morton CL, Kolb EA, Gorlick R, Keir ST, Carol H, Lock R, Maris JM, Wozniak A, Smith MA. Initial testing (Stage 1) of AT13387, an HSP90 inhibitor, by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Apr 29. doi: 10.1002/pbc.23154. [Epub ahead of print] PubMed PMID: 21538821.
  118. Johnson K, McGlynn B, Saggio J, Baniewicz D, Zhuang H, Maris JM, Mosse YP. Safety and efficacy of tandem (131) I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma. Pediatr Blood Cancer. 2011 Apr 14. doi: 10.1002/pbc.23062. [Epub ahead of print] PubMed PMID: 21495159.
  119. Carol H, Boehm I, Reynolds CP, Kang MH, Maris JM, Morton CL, Gorlick R, Kolb EA, Keir ST, Wu J, Wozniak AE, Yang Y, Manfredi M, Ecsedy J, Wang J, Neale G, Houghton PJ, Smith MA, Lock RB. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Cancer Chemother Pharmacol. 2011 Mar 30. [Epub ahead of print] PubMed PMID: 21448591.
  120. Reynolds CP, Kang MH, Keir ST, Gorlick R, Kolb EA, Lock R, Maris JM, Carol H, Morton CL, Billups CA, Smith MA, Houghton PJ. Initial testing of lenalidomide by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Feb 25. doi: 10.1002/pbc.22877. [Epub ahead of print] PubMed PMID: 21360651.
  121. Smith MA, Maris JM, Lock R, Kolb EA, Gorlick R, Keir ST, Carol H, Morton CL, Reynolds CP, Kang MH, Houghton PJ. Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Aug;57(2):268-74. doi: 10.1002/pbc.22797. Epub 2011 Feb 25. PubMed PMID: 21360650; PubMed Central PMCID: PMC3115432.
  122. Houghton PJ, Gorlick R, Kolb EA, Lock R, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Phelps D, Maris JM, Billups C, Smith MA. Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Feb 18. doi: 10.1002/pbc.22935. [Epub ahead of print] PubMed PMID: 21337679.
  123. Kolb EA, Gorlick R, Lock R, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups C, Smith MA, Houghton PJ. Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2011 Apr;56(4):595-603. doi: 10.1002/pbc.22741. Epub 2010 Dec 22. PubMed PMID: 21298745.
  124. Houghton PJ, Lock R, Carol H, Morton CL, Phelps D, Gorlick R, Kolb EA, Keir ST, Reynolds CP, Kang MH, Maris JM, Wozniak AW, Gu Y, Wilson WR, Smith MA. Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2010 Dec 27. [Epub ahead of print] PubMed PMID: 21188727.
  125. Kolb EA, Gorlick R, Lock R, Carol H, Morton CL, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups C, Smith MA, Houghton PJ. Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2010 Dec 22. [Epub ahead of print] PubMed PMID: 21181879.
  126. Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, Simon MC. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res. 2010 Dec 15;70(24):10351-61. Epub 2010 Oct 20. PubMed PMID: 20961996; PubMed Central PMCID: PMC3005134.
  127. Delgado DC, Hank JA, Kolesar J, Lorentzen D, Gan J, Seo S, Kim K, Shusterman S, Gillies SD, Reisfeld RA, Yang R, Gadbaw B, DeSantes KB, London WB, Seeger RC, Maris JM, Sondel PM. Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Res. 2010 Dec 1;70(23):9554-61. Epub 2010 Oct 8. PubMed PMID: 20935224; PubMed Central PMCID: PMC2999644.
  128. Shusterman S, London WB, Gillies SD, Hank JA, Voss SD, Seeger RC, Reynolds CP, Kimball J, Albertini MR, Wagner B, Gan J, Eickhoff J, DeSantes KB, Cohn SL, Hecht T, Gadbaw B, Reisfeld RA, Maris JM, Sondel PM. Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol. 2010 Nov 20;28(33):4969-75. Epub 2010 Oct 4. PubMed PMID: 20921469; PubMed Central PMCID: PMC3020698.
  129. Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK; Children's Oncology Group. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010 Sep 30;363(14):1313-23. PubMed PMID: 20879880; PubMed Central PMCID: PMC2993160.
  130. Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Pediatr Blood Cancer. 2011 Feb;56(2):191-201. doi: 10.1002/pbc.22767. Epub 2010 Sep 9. PubMed PMID: 20830775; PubMed Central PMCID: PMC3006009.
  131. Kolb EA, Gorlick R, Houghton PJ, Morton CL, Neale G, Keir ST, Carol H, Lock R, Phelps D, Kang MH, Reynolds CP, Maris JM, Billups C, Smith MA. Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer. 2010 Oct;55(4):668-77. PubMed PMID: 20806365; PubMed Central PMCID: PMC3004092.
  132. Carol H, Morton CL, Gorlick R, Kolb EA, Keir ST, Reynolds CP, Kang MH, Maris JM, Billups C, Smith MA, Houghton PJ, Lock RB. Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2010 Dec 15;55(7):1329-37. doi: 10.1002/pbc.22710. Epub 2010 Aug 25. PubMed PMID: 20740623; PubMed Central PMCID: PMC2965797.
  133. Keir ST, Maris JM, Lock R, Kolb EA, Gorlick R, Carol H, Morton CL, Reynolds CP, Kang MH, Watkins A, Houghton PJ, Smith MA. Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program. Pediatr Blood Cancer. 2010 Dec 1;55(6):1126-33. PubMed PMID: 20672370.
  134. Morton CL, Houghton PJ, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Maris JM, Keir ST, Wu J, Smith MA. Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program. Pediatr Blood Cancer. 2010 Aug;55(2):295-303. PubMed PMID: 20582972; PubMed Central PMCID: PMC3003870.
  135. Houghton PJ, Morton CL, Gorlick R, Kolb EA, Keir ST, Reynolds CP, Kang MH, Maris JM, Wu J, Smith MA. Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer. 2010 Jul 1;54(7):921-6. PubMed PMID: 20166202; PubMed Central PMCID: PMC3003867.
  136. Maris JM, Morton CL, Gorlick R, Kolb EA, Lock R, Carol H, Keir ST, Reynolds CP, Kang MH, Wu J, Smith MA, Houghton PJ. Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer. 2010 Jul 15;55(1):26-34. PubMed PMID: 20108338; PubMed Central PMCID: PMC2874079.
  137. Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol. 2011 Mar;13(3):298-306. PubMed PMID: 21339191; PubMed Central PMCID: PMC3064607.
  138. Long PM, Stradecki HM, Minturn JE, Wesley UV, Jaworski DM. Differential aminoacylase expression in neuroblastoma. Int J Cancer. 2010 Dec 2. [Epub ahead of print] PubMed PMID: 21128244.
  139. Rothman JA, Das R, Teachey DT, Paessler ME, Nichols KE. Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice. Pediatr Blood Cancer. 2011 Jun 16. doi: 10.1002/pbc.23226. [Epub ahead of print] PubMed PMID: 21681935.
  140. Nallasamy S, Eagle RC Jr, Rorke-Adams L, Nichols KE, Brucker AJ. Eye Findings in X-linked Lymphoproliferative Disorder. Retina. 2011 Mar 9. [Epub ahead of print] PubMed PMID: 21394060.
  141. Teplick A, Kowalski M, Biegel JA, Nichols KE. Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. Eur J Pediatr. 2011 Mar;170(3):285-94. Epub 2011 Jan 6. Review. PubMed PMID: 21210147; PubMed Central PMCID: PMC3086787.
  142. Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol. 2011 Jan;152(1):13-30. doi: 10.1111/j.1365-2141.2010.08442.x. Epub 2010 Nov 18. Review. PubMed PMID: 21083659.
  143. Shlien A, Baskin B, Achatz MI, Stavropoulos DJ, Nichols KE, Hudgins L, Morel CF, Adam MP, Zhukova N, Rotin L, Novokmet A, Druker H, Shago M, Ray PN, Hainaut P, Malkin D. A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes. Am J Hum Genet. 2010 Nov 12;87(5):631-42. PubMed PMID: 21056402; PubMed Central PMCID: PMC2978979.
  144. Das R, Sant'Angelo DB, Nichols KE. Transcriptional control of invariant NKT cell development. Immunol Rev. 2010 Nov;238(1):195-215. doi: 10.1111/j.1600-065X.2010.00962.x. PubMed PMID: 20969594; PubMed Central PMCID: PMC2965566.
  145. Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, Heath PT, Steward CG, Smith O, O'Meara A, Kerrigan H, Mahlaoui N, Cavazzana-Calvo M, Fischer A, Moshous D, Blanche S, Pachlopnick-Schmid J, Latour S, de Saint-Basile G, Albert M, Notheis G, Rieber N, Strahm B, Ritterbusch H, Lankester A, Hartwig NG, Meyts I, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Bonanomi S, Peters C, Kalwak K, Pasic S, Sedlacek P, Jazbec J, Kanegane H, Nichols KE, Hanson IC, Kapoor N, Haddad E, Cowan M, Choo S, Smart J, Arkwright PD, Gaspar HB. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011 Jan 6;117(1):53-62. Epub 2010 Oct 6. PubMed PMID: 20926771.
  146. Nichols KE, Arceci RJ. BRAF, a piece of the LCH puzzle. Blood. 2010 Sep 16;116(11):1825-7. PubMed PMID: 20847208.
  147. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010 Dec;174(6):741-52. Epub 2010 Oct 6. PubMed PMID: 21128798; PubMed Central PMCID: PMC3080023.
  148. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010 Jul 21;102(14):1083-95. Epub 2010 Jul 15. PubMed PMID: 20634481; PubMed Central PMCID: PMC2907408.
  149. Henderson TO, Friedman DL, Meadows AT. Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics. 2010 Jul;126(1):129-36. Epub 2010 Jun 14. Review. PubMed PMID: 20547645.
  150. Seif AE, Reilly AF, Rheingold SR. Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children's Hospital of Philadelphia experience and review of the literature. J Pediatr Hematol Oncol. 2010 Nov;32(8):e349-52. Review. PubMed PMID: 20962675.
  151. Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, Sullivan KE. The efficacy of influenza vaccination in a pediatric oncology population. J Pediatr Hematol Oncol. 2010 Jul;32(5):e177-81. PubMed PMID: 20485201.
  152. Kazak, AE, Hazen RA, Eder M, Drotar D, Zyzanski S, Reynolds AE, Reynolds CP, Kodish E, Noll RB; Multi-Site Intervention Study to Improve Consent Research Team. A feasibility trial of a video intervention to improve informed consent for parents of children with leukemia. Pediatr Blood Cancer. 2010 Jul 15;55(1):113-8. PubMed PMID: 20063423; PubMed Central PMCID: PMC2874099.
  153. Paisley MA, Kang TI, Insogna IG, Rheingold SR. Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy. Pediatr Blood Cancer. 2011 Jul 1;56(7):1088-91. doi: 10.1002/pbc.22939. Epub 2011 Feb 25. PubMed PMID: 21360653.
  154. Seif AE, Sutter JA, Rheingold SR. Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy. Pediatr Blood Cancer. 2010 Aug;55(2):386-9. PubMed PMID: 20582966.
  155. Yap TY, Yamokoski AD, Hizlan S, Zyzanski SJ, Angiolillo AL, Rheingold SR, Baker JN, Kodish ED; Phase I Informed Consent (POIC) Research Team. Informed consent for pediatric phase 1 cancer trials: physicians' perspectives. Cancer. 2010 Jul 1;116(13):3244-50. PubMed PMID: 20564626; PubMed Central PMCID: PMC2892009.
  156. Commander LA, Seif AE, Insogna IG, Rheingold SR. Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma. Br J Haematol. 2010 Aug;150(3):345-51. Epub 2010 May 26. PubMed PMID: 20528871.
  157. Pai AL, Schwartz LA. Introduction to the special section: Health care transitions of adolescents and young adults with pediatric chronic conditions. J Pediatr Psychol. 2011 Mar;36(2):129-33. Epub 2010 Nov 30. PubMed PMID: 21118867.
  158. Silber JH, Rosenbaum PR, Even-Shoshan O, Mi L, Kyle FA, Teng Y, Bratzler DW, Fleisher LA. Estimating Anesthesia Time Using the Medicare Claim: A Validation Study. Anesthesiology. 2011 Jun 30. [Epub ahead of print] PubMed PMID: 21720242.
  159. Kaplan HC, Lorch SA, Pinto-Martin J, Putt M, Silber JH. Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality. BMC Health Serv Res. 2011 Jan 31;11:22. PubMed PMID: 21281485; PubMed Central PMCID: PMC3045285.
  160. Kaestner R, Silber JH. Evidence on the efficacy of inpatient spending on Medicare patients. Milbank Q. 2010 Dec;88(4):560-94. doi: 10.1111/j.1468-0009.2010.00612.x. PubMed PMID: 21166869.
  161. Armstrong K, Randall TC, Polsky D, Moye E, Silber JH. Racial differences in surgeons and hospitals for endometrial cancer treatment. Med Care. 2011 Feb;49(2):207-14. PubMed PMID: 21150796.
  162. Press MJ, Silber JH, Rosen AK, Romano PS, Itani KM, Zhu J, Wang Y, Even-Shoshan O, Halenar MJ, Volpp KG. The impact of resident duty hour reform on hospital readmission rates among Medicare beneficiaries. J Gen Intern Med. 2011 Apr;26(4):405-11. Epub 2010 Nov 6. PubMed PMID: 21057883; PubMed Central PMCID: PMC3055962.
  163. Volpp KG, Friedman W, Romano PS, Rosen A, Silber JH. Residency training at a crossroads: duty-hour standards 2010. Ann Intern Med. 2010 Dec 21;153(12):826-8. Epub 2010 Oct 18. PubMed PMID: 20956679.
  164. Silber JH, Kaestner R, Even-Shoshan O, Wang Y, Bressler LJ. Aggressive treatment style and surgical outcomes. Health Serv Res. 2010 Dec;45(6 Pt 2):1872-92. doi: 10.1111/j.1475-6773.2010.01180.x. Epub 2010 Sep 28. PubMed PMID: 20880043; PubMed Central PMCID: PMC3029844.
  165. Neuman MD, David G, Silber JH, Schwartz JS, Fleisher LA. Changing access to emergency care for patients undergoing outpatient procedures at ambulatory surgery centers: evidence from Florida. Med Care Res Rev. 2011 Apr;68(2):247-58. Epub 2010 Jul 30. PubMed PMID: 20675344.
  166. Silber JH, Rosenbaum PR, Brachet TJ, Ross RN, Bressler LJ, Even-Shoshan O, Lorch SA, Volpp KG. The Hospital Compare mortality model and the volume-outcome relationship. Health Serv Res. 2010 Oct;45(5 Pt 1):1148-67. doi: 10.1111/j.1475-6773.2010.01130.x. PubMed PMID: 20579125.
  167. Friese CR, Silber JH, Aiken LH. National Cancer Institute Cancer Center designation and 30-day mortality for hospitalized, immunocompromised cancer patients. Cancer Invest. 2010 Aug;28(7):751-7. PubMed PMID: 20504224; PubMed Central PMCID: PMC2906620.
  168. Cooper A, van Doorninck J, Ji L, Russell D, Ladanyi M, Shimada H, Krailo M, Womer RB, Hsu JH, Thomas D, Triche TJ, Sposto R, Lawlor ER. Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group. Clin Cancer Res. 2011 Jan 1;17(1):56-66. Epub 2010 Nov 3. PubMed PMID: 21047978.
  169. Womer RB. Outpatient high-dose methotrexate: proceed with extreme caution, if at all. Pediatr Blood Cancer. 2010 Dec 15;55(7):1250-1. PubMed PMID: 20981687.
  170. Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2011 May;204(5):227-44. PubMed PMID: 21665176.

    171. Non-Oncology CCCR Faculty

  171. Rowh MA, Demicco A, Horowitz JE, Yin B, Yang-Iott KS, Fusello AM, Hobeika E, Reth M, Bassing CH. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations. Oncogene. 2011 May 30. [Epub ahead of print] PubMed PMID: 21625223.
  172. Sherman MH, Bassing CH, Teitell MA. Regulation of cell differentiation by the DNA damage response. Trends Cell Biol. 2011 May;21(5):312-9. Epub 2011 Feb 25. PubMed PMID: 21354798; PubMed Central PMCID: PMC3089693.
  173. Gapud EJ, Dorsett Y, Yin B, Callen E, Bredemeyer A, Mahowald GK, Omi KQ, Walker LM, Bednarski JJ, McKinnon PJ, Bassing CH, Nussenzweig A, Sleckman BP. Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2022-7. Epub 2011 Jan 18. PubMed PMID: 21245316; PubMed Central PMCID: PMC3033293.
  174. Helmink BA, Tubbs AT, Dorsett Y, Bednarski JJ, Walker LM, Feng Z, Sharma GG, McKinnon PJ, Zhang J, Bassing CH, Sleckman BP. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature. 2011 Jan 13;469(7329):245-9. Epub 2010 Dec 15. Erratum in: Nature. 2011 Apr 14;472(7342):247. PubMed PMID: 21160476.
  175. DeMicco A, Bassing CH. Deciphering the DNA damage histone code. Cell Cycle. 2010 Oct 1;9(19):3845. PubMed PMID: 20948284; PubMed Central PMCID: PMC3005587.
  176. Yin B, Yang-Iott KS, Chao LH, Bassing CH. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma. Blood. 2011 Jan 6;117(1):175-85. Epub 2010 Oct 14. PubMed PMID: 20947684; PubMed Central PMCID: PMC3037742.
  177. Brady BL, Steinel NC, Bassing CH. Antigen receptor allelic exclusion: an update and reappraisal. J Immunol. 2010 Oct 1;185(7):3801-8. Review. PubMed PMID: 20858891; PubMed Central PMCID: PMC3008371.
  178. Brady BL, Oropallo MA, Yang-Iott KS, Serwold T, Hochedlinger K, Jaenisch R, Weissman IL, Bassing CH. Position-dependent silencing of germline Vß segments on TCRß alleles containing preassembled VßDJßCß1 genes. J Immunol. 2010 Sep 15;185(6):3564-73. Epub 2010 Aug 13. PubMed PMID: 20709953; PubMed Central PMCID: PMC2933292.
  179. Zha S, Bassing CH, Sanda T, Brush JW, Patel H, Goff PH, Murphy MM, Tepsuporn S, Gatti RA, Look AT, Alt FW. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification. J Exp Med. 2010 Jul 5;207(7):1369-80. Epub 2010 Jun 21. PubMed PMID: 20566716; PubMed Central PMCID: PMC2901073.
  180. Steinel NC, Brady BL, Carpenter AC, Yang-Iott KS, Bassing CH. Posttranscriptional silencing of VbetaDJbetaCbeta genes contributes to TCRbeta allelic exclusion in mammalian lymphocytes. J Immunol. 2010 Jul 15;185(2):1055-62. Epub 2010 Jun 18. PubMed PMID: 20562258; PubMed Central PMCID: PMC2920457.
  181. Liu X, Karnell JL, Yin B, Zhang R, Zhang J, Li P, Choi Y, Maltzman JS, Pear WS, Bassing CH, Turka LA. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest. 2010 Jul 1;120(7):2497-507. PubMed PMID: 20516645; PubMed Central PMCID: PMC2898609.
  182. Ortiz-Gonzalez XR, Venneti S, Biegel JA, Rorke-Adams LB, Porter BE. Ganglioglioma arising from dysplastic cortex. Epilepsia. 2011 Jun 10. doi: 10.1111/j.1528-1167.2011.03124.x. [Epub ahead of print] PubMed PMID: 21668439.
  183. Dougherty MJ, Wilmoth DM, Tooke LS, Shaikh TH, Gai X, Hakonarson H, Biegel JA. Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies. Cancer Genet. 2011 Jan;204(1):26-38. PubMed PMID: 21356189.
  184. Plon SE, Wheeler DA, Strong LC, Tomlinson GE, Pirics M, Meng Q, Cheung HC, Begin PR, Muzny DM, Lewis L, Biegel JA, Gibbs RA. Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel. Cancer Genet. 2011 Jan;204(1):19-25. PubMed PMID: 21356188; PubMed Central PMCID: PMC3075924.
  185. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011 Jan;56(1):7-15. PubMed PMID: 21108436; PubMed Central PMCID: PMC3086793.
  186. Bruggers CS, Bleyl SB, Pysher T, Barnette P, Afify Z, Walker M, Biegel JA. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer. 2011 Jul 1;56(7):1026-31. doi: 10.1002/pbc.22757. Epub 2010 Sep 16. PubMed PMID: 20848638.
  187. Murray JC, Donahue DJ, Malik SI, Dzurik YB, Braly EZ, Dougherty MJ, Eaton KW, Biegel JA. Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome. J Neurooncol. 2011 May;102(3):509-14. Epub 2010 Aug 21. PubMed PMID: 20730472; PubMed Central PMCID: PMC2998545.
  188. Park TJ, Curran T: Alternative Splicing Disabled by Nova2. Neuron Page: 66(6): 811-3, June 2010
  189. Hallock Peter T, Xu Chong-Feng, Park Tae-Ju, Neubert Thomas A, Curran Tom, Burden Steven J: Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L. Genes & development 24(21): 2451-61, Nov 2010.
  190. Seidel Kerstin, Ahn Christina P, Lyons David, Nee Alexander, Ting Kevin, Brownell Isaac, Cao Tim, Carano Richard A D, Curran Tom, Schober Markus, Fuchs Elaine, Joyner Alexandra, Martin Gail R, de Sauvage Frederic J, Klein Ophir D: Hedgehog signaling regulates the generation of ameloblast progenitors in the continuously growing mouse incisor. Development (Cambridge, England) 137(22): 3753-61, Nov 2010.
  191. Parsons D Williams, Li Meng, Zhang Xiaosong, Jones Siân, Leary Rebecca J, Lin Jimmy Cheng-Ho, Boca Simina M, Carter Hannah, Samayoa Josue, Bettegowda Chetan, Gallia Gary L, Jallo George I, Binder Zev A, Nikolsky Yuri, Hartigan James, Smith Doug R, Gerhard Daniela S, Fults Daniel W, Vandenberg Scott, Berger Mitchel S, Marie Suely Kazue Nagahashi, Shinjo Sueli Mieko Oba, Clara Carlos, Phillips Peter C, Minturn Jane E, Biegel Jaclyn A, Judkins Alexander R, Resnick Adam C, Storm Phillip B, Curran Tom, He Yiping, Rasheed B Ahmed, Friedman Henry S, Keir Stephen T, McLendon Roger, Northcott Paul A, Taylor Michael D, Burger Peter C, Riggins Gregory J, Karchin Rachel, Parmigiani Giovanni, Bigner Darell D, Yan Hai, Papadopoulos Nick, Vogelstein Bert, Kinzler Kenneth W, Velculescu Victor E: The Genetic Landscape of the Childhood Cancer Medulloblastoma. Science (New York, N.Y.) Dec 2010.
  192. Brechbiel JL, Ng JMY, Curran T: PTHrP treatment fails to rescue bone defects caused by Hedgehog pathway inhibition in young mice. Toxicologic Pathology 39 (3) 478-85, Apr 2011.
  193. Curran Tom: Mouse models and mouse supermodels. EMBO molecular medicine 2(10): 385-6; author reply 386-7, Oct 2010.
  194. Ng JM, Curran T: The Hedgehog's tale: developing strategies for targeting cancer. Nature Reviews Cancer 11(7): 493-501, May 2011.
  195. Curran T, Targeting Children's Brain Tumors: Development of hedgehog Pathway Inhibitors for Medulloblastoma. In Two Faces of Evil: Cancer and Neurodegeneration; Research Perspectives in Alzheimer's Disease. Curran T, Christen Y. Eds: Springer, 1: 57-71, 2010.
  196. Curran, T. Christen, Y (Eds): Two Faces of Evil: Cancer and Neurodegeneration, Research Perspectives in Alzheimer's Disease. Foundation IPSEN. Springer, 2010.
  197. Schwartz DM, Sestokas AK, Dormans JP, Vaccaro AR, Hilibrand AS, Flynn JM, Li PM, Shah SA, Welch W, Drummond DS, Albert TJ. Transcranial electric motor evoked potential monitoring during spine surgery: is it safe? Spine (Phila Pa 1976). 2011 Jun;36(13):1046-9. PubMed PMID: 21217447.
  198. Sharma S, Gao X, Londono D, Devroy SE, Mauldin KN, Frankel JT, Brandon JM, Zhang D, Li QZ, Dobbs MB, Gurnett CA, Grant SF, Hakonarson H, Dormans JP, Herring JA, Gordon D, Wise CA. Genome-wide association studies of adolescent idiopathic scoliosis suggest candidate susceptibility genes. Hum Mol Genet. 2011 Apr 1;20(7):1456-66. Epub 2011 Jan 7. PubMed PMID: 21216876; PubMed Central PMCID: PMC3049353.
  199. Dormans JP. Establishing a standard of care for neuromonitoring during spinal deformity surgery. Spine (Phila Pa 1976). 2010 Dec 1;35(25):2180-5. Review. PubMed PMID: 21102291.
  200. Santore MT, Behar BJ, Blinman TA, Doolin EJ, Hedrick HL, Mattei P, Nance ML, Adzick NS, Flake AW. Hepaticoduodenostomy vs hepaticojejunostomy for reconstruction after resection of choledochal cyst. J Pediatr Surg. 2011 Jan;46(1):209-13. PubMed PMID: 21238669.
  201. Hwynn N, Hass CJ, Zeilman P, Romrell J, Dai Y, Wu SS, Foote KD, Subramony SH, Oyama G, Velez-Lago F, Fernandez HH, Resnick AS, Malaty IA, Okun MS. Steady or not following thalamic deep brain stimulation for essential tremor. J Neurol. 2011 Mar 27. [Epub ahead of print] PubMed PMID: 21442464.
  202. Williams NN, Mittal MK, Dumon KR, Matika G, Pray LA, Resnick AS, Morris JB. Penn Medicine Clinical Simulation Center. J Surg Educ. 2011 Jan-Feb;68(1):83-6. PubMed PMID: 21292223.
  203. Ullman M, Vedam-Mai V, Krock N, Sudhyadhom A, Foote KD, Yachnis AT, Merritt S, Resnick AS, Zeilman P, Okun MS. A pilot study of human brain tissue post-magnetic resonance imaging: information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN). Neuroimage. 2011 Jan;54 Suppl 1:S233-7. Epub 2010 Sep 19. PubMed PMID: 20849960.
  204. Elia J, Gai X, Hakonarson H, White PS. Structural variations in attention-deficit hyperactivity disorder. Lancet. 2011 Jan 29;377(9763):377-8; author reply 378. PubMed PMID: 21277432.
  205. Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, D'arcy M, O'Hara RJ, Goldmuntz E, Grice DE, Shaikh TH, Hakonarson H, Buxbaum JD, Elia J, White PS. Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry. 2011 Mar 1. [Epub ahead of print] PubMed PMID: 21358714.
  206. Daftari IK, Mishra KK, O'Brien JM, Tsai T, Park SS, Sheen M, Phillips TL. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning. Med Phys. 2010 Oct;37(10):5199-207. PubMed PMID: 21089753.